Saluda Medical, Inc. (ASX:SLD)
Australia · Delayed Price · Currency is AUD 0.4000
-0.0100 (-2.44%)
At close: Sep 22, 2026
Saluda Medical Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
| 90.18 | 70.36 | 51.68 | 22.23 | |
Revenue Growth | 28.17% | 36.13% | 132.45% | - |
Cost of Revenue | 46.09 | 37.6 | 28.57 | 18.2 |
Gross Profit | 44.08 | 32.76 | 23.11 | 4.04 |
Selling, General & Admin | 154.31 | 115.35 | 93.05 | 68.15 |
Research & Development | 34.24 | 35.46 | 29.2 | 28.11 |
Other Operating Expenses | 0.02 | - | - | - |
Operating Expenses | 188.58 | 150.81 | 122.25 | 96.26 |
Operating Income | -144.49 | -118.05 | -99.14 | -92.22 |
Interest Expense | -9.42 | -27.24 | -5 | -4.67 |
Interest & Investment Income | 2.68 | 2.01 | 5.47 | 3.21 |
Currency Exchange Gain (Loss) | -0.2 | 1.65 | 0.11 | 1.43 |
Other Non Operating Income (Expenses) | 7.08 | -7.15 | 1 | 0.7 |
EBT Excluding Unusual Items | -144.37 | -148.77 | -97.55 | -91.55 |
Merger & Restructuring Charges | -1.7 | - | - | - |
Other Unusual Items | -2.8 | - | - | - |
Pretax Income | -148.87 | -148.77 | -97.55 | -91.55 |
Income Tax Expense | 0.7 | 0.53 | 0.27 | 0.61 |
Net Income | -149.57 | -149.3 | -97.83 | -92.16 |
Preferred Dividends & Other Adjustments | 90.04 | - | - | - |
Net Income to Common | -239.61 | -149.3 | -97.83 | -92.16 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 162 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 162 | 3 | 3 | 3 |
Shares Change | 4887.27% | 0.13% | 0.06% | - |
EPS (Basic) | -1.48 | -45.92 | -30.13 | -28.40 |
EPS (Diluted) | -1.48 | -45.92 | -30.13 | -28.40 |
EPS Growth | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Free Cash Flow | -116.72 | -119.51 | -94.4 | -88.03 |
Free Cash Flow Per Share | -0.72 | -36.76 | -29.07 | -27.13 |
Gross Margin | 48.89% | 46.56% | 44.72% | 18.17% |
Operating Margin | -160.24% | -167.79% | -191.82% | -414.78% |
Profit Margin | -265.72% | -212.21% | -189.29% | -414.52% |
Free Cash Flow Margin | -129.44% | -169.87% | -182.66% | -395.93% |
EBITDA | -142.69 | -116.4 | -97.25 | -90.94 |
EBITDA Margin | -158.23% | -165.45% | -188.17% | - |
D&A For EBITDA | 1.81 | 1.65 | 1.89 | 1.29 |
EBIT | -144.49 | -118.05 | -99.14 | -92.22 |
EBIT Margin | -160.24% | -167.79% | -191.82% | - |